News briefs from the January issue of Chest

DATA SHOWS OMALIZUMAB SAFE AND EFFECTIVE FOR MODERATE TO SEVERE ASTHMA
New research suggests that subcutaneous omalizumab is safe and effective an add-on treatment to corticosteroids for moderate to severe asthma in children and adults. R…

Chest news briefs: CPAP may cause facial changes

USE OF NASAL CPAP MAY CAUSE CRANIOFACIAL CHANGES
The use of a nasal continuous positive airway pressure (nCPAP) machine for more than 2 years may cause craniofacial changes in adults with obstructive sleep apnea (OSA). Researchers from The Univer…